stockrowIndivior Pharmaceuticals Inc.
SUPN Healthcare Drug Manufacturers Specialty & Generic
Indivior Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 4.29% from fiscal 2024.
- Revenue
- +13.4%
- EPS
- +241.5%
- Free cash flow
- +240.7%
- Total debt
- +51.6%
Quarter to September 2026, against a year earlier
Follow SUPN
Alert me
Indivior Pharmaceuticals Inc. (SUPN) Debt to equity
Indivior Pharmaceuticals Inc.'s debt to equity at the end of the quarter to 30 September 2026 was −8.1×, down 4.9× from fiscal 2025 (−3.3×). Over the past ten years it has ranged from −3.3× (fiscal 2025) to 4.7× (fiscal 2022) — the current reading is the lowest in ten years. That is below the Drug Manufacturers Specialty & Generic industry median of 0.0× and below the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | −3.3× | — |
| FY2024 | −1.0× | — |
| FY2023 | −1.3× | — |
| FY2022 | 4.7× | 294.76% |
| FY2021 | 1.2× | (58.23%) |
| FY2020 | 2.9× | 151.65% |
| FY2019 | 1.1× | (68.94%) |
| FY2018 | 3.7× | — |
| FY2017 | −2.4× | — |
| FY2016 | −1.8× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | −8.1× | — |
| Jun 2026 | −2.3× | — |
| Mar 2026 | −3.4× | — |
| Dec 2025 | −3.3× | — |
| 43 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| SUPN Indivior Pharmaceuticals Inc. | −8.1× |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 0.0× |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 0.0× |
| RDY Dr. Reddy's Laboratories Ltd compare | 0.2× |
| LNTH Lantheus Holdings, Inc. compare | 0.4× |
| ALKS Alkermes plc compare | 0.8× |
| LQDA Liquidia Corporation compare | 0.9× |
| HIMS Hims & Hers Health, Inc. compare | 4.2× |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 6.0× |
| Drug Manufacturers Specialty & Generic industry median | 0.0× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on SUPN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement